Forbes reported on recent drug filings submitted to the FDA and the European Medicines Agency.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Forbes reported on recent drug filings submitted to the FDA and the European Medicines Agency.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
Nothing else this week.
Related events
- Menarini Group and NewAmsterdam Pharma Company N.V. are collaborating on drug development, seeking marketing authorization in Europe through the EMA and EC process.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- FDA approval coincided with Donald Trump's press conference on November 11, 2026.
- Anavex Life Sciences submitted data for FDA discussions and received scientific advice from the EMA.
- FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.